BridgeBio Oncology Therapeutics, Inc. Payments to Acquire Investments to be Held in Decommissioning Trust Fund
BridgeBio Oncology Therapeutics, Inc. (BBOT) reported Payments to Acquire Investments to be Held in Decommissioning Trust Fund of $184.00 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Cash Flow
us-gaap:PaymentsToInvestInDecommissioningFund · last filed 2024-05-15
- BridgeBio Oncology Therapeutics, Inc. payments to acquire investments to be held in decommissioning trust fund for the quarter ending 2024-03-31 was $184.00M.
| Period end | Payments to Acquire Investments to be Held in Decommissioning Trust Fund 3 month |
|---|---|
| 2024-03-31 | $184.00M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |